TMC435-TiDP16-C206: A Safety and Efficacy Study in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment - No Study Results Posted

TMC435-TiDP16-C206: A Safety and Efficacy Study in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment (ASPIRE)

This study has been completed.

Study NCT00980330 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: September 10, 2009 Last Updated: April 27, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2011
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: June 20, 2011